Legislative and Regulatory Updates in the Health Sector: An Insightful Look into Washington, D.C.’s Healthcare Landscape

Holland & Knight Health Update: March 5, 2024 | Insights

The health sector in Washington, D.C. is experiencing a flurry of legislative and regulatory developments that are closely monitored by Holland & Knight Health Dose. This article provides an update on the various topics that affect the industry this week.

The House and Senate are both expected to vote on health legislation, with the Senate AI Working Group discussing health priorities at a hearing in the Senate Finance Committee. Additionally, Senate HELP Committee GOP members are seeking information on short-term limited duration insurance plans as a final rule heads to the Office of Management and Budget.

The House E&C Committee’s Subcommittee on Health is considering legislation on rare diseases, while announcements of retirements have been made in the health sector. Discussions on PBM reform are ongoing, and the White House Budget Office is reviewing CMS’ 2025 MA and Part D final rule.

The Biden-Harris Administration has issued final guidance to help people with Medicare prescription drug coverage manage costs, and the call for MIPS improvement activities for 2024 is open. ARPA-H funds have been allocated for an AI-driven drug repurposing project, and MACPAC has announced a public meeting in March 2024.

In addition, stakeholder input is being requested for a NASEM assessment of NIH research on women’s health, while the FTC, DOJ, and HHS have launched a private equity inquiry into healthcare practices. The HHS Health Information Technology Advisory Committee and HRSA are also seeking input on various processes related to health information and screening for heritable disorders in newborns and children.

Overall, these developments highlight the importance of staying informed about legislative and regulatory changes affecting the health sector in Washington, D.C., which can be done by visiting Holland & Knight Health Dose’s website for updates on all these topics.

Leave a Reply